The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting outcomes of advanced non-small cell lung cancer patients treated with PD-1/PDL-1 inhibitors: Independent international validation of the iSEND model.
 
Wungki Park
No Relationships to Disclose
 
Laura Mezquita
No Relationships to Disclose
 
Naoyuki Okabe
No Relationships to Disclose
 
Deukwoo Kwon
No Relationships to Disclose
 
Diana Saravia
No Relationships to Disclose
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Counsyl; Foundation Medicine; Guardant Health
Speakers' Bureau - Genentech/Roche; Genentech/Roche; merck
Travel, Accommodations, Expenses - Hanmi
 
Amrita Desai
No Relationships to Disclose
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MSD Oncology; Novartis; Pfizer; Roche
 
Caroline Caramella
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
 
Raja Mudad
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Mohammad Jahanzeb
Honoraria - Foundation Medicine
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - Foundation Medicine
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Callisto Pharmaceuticals (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Foundation Medicine; Helsinn Therapeutics
 
Hiroyuki Suzuki
No Relationships to Disclose
 
Benjamin Besse
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Inivata (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); OncoMed (Inst); Onxeo (Inst); ose pharma (Inst); ose pharma (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Novartis; Pfizer; Pierre Fabre; Roche
 
Gilberto Lopes
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Merck Sharp & Dohme (Inst)